JDOC JPMorgan Healthcare Leaders ETF

ETF

ETF quote, holdings, sector allocation, technicals, and options analytics. Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

JDOC — —
Key stats
About

JPMorgan Healthcare Leaders ETF (JDOC) ETF

No description available.

Exchange
XNAS
Inception
2023-11-01
Has Options
No
Fund profile
holdings as of Apr 30, 2026SEC filingthrough Jul 2026flows, SEC filings
Sector Health Care#26 of 29 by assets JPMorgan Global Actively managed
Expense ratio
0.65%
prospectus, filed Apr 30, 2026
Assets
$9.1M
shares × price, Oct 9, 2026
Trailing yield
0.85%
paid annual
Average daily volume
$14K
30 sessions
Holdings
66
top 10 are 46.6%
Listed
Nov 1, 2023
Nasdaq
Closure risk, 12 months
11%
elevated: trading volume · model
FrenzyCap ETF score
17
how it is built
Cost14
Liquidity0
Scale0
Diversification61

Moves with. US large-cap stocks (19% of its variance, beta 0.65); Developed markets ex-US over US (12% of its variance, beta 0.50); Long Treasuries (5% of its variance, beta 0.23); Value over growth (4% of its variance, beta 0.30). These factors explain 42% of its daily moves over the last year.

Stated objective. The Fund seeks to provide long-term capital appreciation. (from the fund's prospectus)

All 66 holdingsFlow historySimilar fundsOverlap toolAll Health Care ETFs

Fund flows
through Jul 2026SEC filings
Jul 2026
$0
latest reported month
Latest 3 months
−$2.8M
−30.6% of assets
Latest 12 months
−$22K
−0.2% of assets
Aug 2025: $0Sep 2025: $0SepOct 2025: $0Nov 2025: $0NovDec 2025: $0Jan 2026: $0JanFeb 2026: $0Mar 2026: +$1.3MMarApr 2026: +$1.4M+$1.4MMay 2026: −$2.8M−$2.8MMayJun 2026: $0Jul 2026: $0Jul
View as a table
Net flows of JDOC by month, Aug 2025 to Jul 2026
MonthNet flow
Jul 2026$0
Jun 2026$0
May 2026−$2.8M
Apr 2026+$1.4M
Mar 2026+$1.3M
Feb 2026$0
Jan 2026$0
Dec 2025$0
Nov 2025$0
Oct 2025$0
Sep 2025$0
Aug 2025$0

Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 33 months ago

Similar funds
FundOverlapFeeAssets1Y
TRUHVanEck Healthcare TruSector ETF55%—$833K—compare
FHLCFidelity MSCI Health Care Index ETF55%0.08%$3.5B+18.9%compare
XLVState Street Health Care Select Sector SPDR ETF54%0.08%$43.5B+18.2%compare
VHTVanguard Health Care ETF53%0.09%$19.3B+18.4%compare
HRTSTema ETF Trust Tema Heart & Health ETF50%0.75%$54M+11.2%compare

Ranked by how much of the two portfolios is the same securities.

Look-through: what the holdings say
weights as of Apr 30, 2026SEC filing
Holdings vs fair value
+11.1%
37% under, 13% over · 73% covered
Price / earnings
71.2
12% loss-making · 74% covered
Price / book · sales
4.0 · 1.3
revenue growth +7.5%
Above 200-day average
71%
50% above 50-day · by weight
Short interest
3.1%
of float, weighted · 3.4 days to cover
Insider buying
3%
of weight had net insider buying, 90 days; 54% net selling
13F holders
+2.5%
change in shares held by institutions, latest quarter
Reporting earnings
12.2%
of weight in 7 days; 20.3% in 14
Largest contributors below fair value
BMY+50%UNH+29%CVS+50%MCK+50%CAH+50%
Largest contributors above fair value
ISRG−26%MRK−14%DHR−19%ABBV−5%LLY−3%

Each figure is the fund's holdings weighted by position size, using our data on those stocks, and covers only the share of the stock holdings stated. Positive fair value means the holdings trade below our estimate.

What changed in the portfolio
Jan 31, 2026 → Apr 30, 2026
ActionHoldingWeight beforeWeight afterShares vs flows
ExitRoche Holding AG2.92%——
New positionRoche Holding AG—2.65%—
DecreaseMedtronic plc3.10%0.59%−77.0%
IncreaseUNHUnitedHealth Group, Inc.3.49%5.83%+23.2%
ExitEssilorLuxottica SA1.92%——
IncreaseISRGIntuitive Surgical, Inc.1.35%2.96%+129.8%
IncreaseTMOThermo Fisher Scientific, Inc.1.67%3.19%+118.8%
New positionCNCCentene Corp.—1.32%—
DecreaseArgenx SE2.09%0.82%−60.0%
DecreaseDHRDanaher Corp.3.16%1.90%−29.9%

10 new, 9 exited, 12 increased and 15 decreased between the fund's two latest holdings reports; turnover 20.7%. Full holdings and history

Under the hood
fiscal year to Oct 31, 2025SEC census
Authorized participants
2 active
of 16 with agreements; top 3 did 100%
Created · redeemed
$2.7M · $1.4M
over the fiscal year
Redemptions in kind
99%
creations 99% in kind
Creation unit
25,000
shares
Securities lending
authorized, none lent

From the fund's annual census filing with the SEC. In-kind redemptions are what let an ETF shed appreciated securities without realising gains.

ETF Profile
holdings as of 2026-10-31
Holdings
65
AUM
$8.7M
Provider
Nport
Inception
2023-11-01
Exchange
XNAS
Data As Of
2026-10-31
Expense Ratio
0.65%
Dividend Yield
0.85%
Distribution
Annual
Recent distributions
Ex-Date Pay Date Amount Type
2025-12-16 2025-12-18 $0.5121 CD
2024-12-24 2024-12-27 $0.3276 SC
2024-12-16 2024-12-18 $2.4890 CD
2023-12-19 2023-12-22 $0.0796 CD
Asset Allocation
Top Holdings
top 50 of 65 holdings
Symbol Name Weight % Asset Class Country
JNJ Johnson & Johnson 7.43% Equity (common) US
LLY Eli Lilly & Co. 7.20% Equity (common) US
ABBV AbbVie, Inc. 5.41% Equity (common) US
MRK Merck & Co., Inc. 5.11% Equity (common) US
— AstraZeneca plc 4.76% Equity (common) GB
— Novo Nordisk A/S 3.65% Equity (common) DK
UNH UnitedHealth Group, Inc. 3.49% Equity (common) US
DHR Danaher Corp. 3.16% Equity (common) US
— Medtronic plc 3.10% Equity (common) IE
— Roche Holding AG 2.92% Equity (common) CH
BMY Bristol-Myers Squibb Co. 2.43% Equity (common) US
BSX Boston Scientific Corp. 2.42% Equity (common) US
CVS CVS Health Corp. 2.40% Equity (common) US
MCK McKesson Corp. 2.09% Equity (common) US
— Argenx SE 2.09% Equity (common) NL
REGN Regeneron Pharmaceuticals, Inc. 2.09% Equity (common) US
— Lonza Group AG 1.95% Equity (common) CH
— EssilorLuxottica SA 1.92% Equity (common) FR
— Hoya Corp. 1.91% Equity (common) JP
— UCB SA 1.89% Equity (common) BE
VRTX Vertex Pharmaceuticals, Inc. 1.84% Equity (common) US
SYK Stryker Corp. 1.71% Equity (common) US
TMO Thermo Fisher Scientific, Inc. 1.67% Equity (common) US
CAH Cardinal Health, Inc. 1.66% Equity (common) US
EW Edwards Lifesciences Corp. 1.65% Equity (common) US
IQV IQVIA Holdings, Inc. 1.43% Equity (common) US
ISRG Intuitive Surgical, Inc. 1.35% Equity (common) US
— Teva Pharmaceutical Industries Ltd. 1.23% Equity (common) IL
— Fresenius SE & Co. KGaA 1.20% Equity (common) DE
— Novartis AG 1.14% Equity (common) CH
— Sartorius AG 1.04% Equity (common) DE
BIIB Biogen, Inc. 0.94% Equity (common) US
AXSM Axsome Therapeutics, Inc. 0.90% Equity (common) US
IONS Ionis Pharmaceuticals, Inc. 0.89% Equity (common) US
APGE Apogee Therapeutics, Inc. 0.83% Equity (common) US
NBIX Neurocrine Biosciences, Inc. 0.77% Equity (common) US
ASND Ascendis Pharma A/S 0.77% Equity (common) DK
— Genmab A/S 0.74% Equity (common) DK
UTHR United Therapeutics Corp. 0.73% Equity (common) US
IMNM Immunome, Inc. 0.70% Equity (common) US
IRON Disc Medicine, Inc. 0.67% Equity (common) US
— Daiichi Sankyo Co. Ltd. 0.67% Equity (common) JP
VRDN Viridian Therapeutics, Inc. 0.66% Equity (common) US
DYN Dyne Therapeutics, Inc. 0.65% Equity (common) US
CGON CG oncology, Inc. 0.62% Equity (common) US
— Convatec Group plc 0.58% Equity (common) GB
RVMD Revolution Medicines, Inc. 0.50% Equity (common) US
WAT Waters Corp. 0.49% Equity (common) US
CYTK Cytokinetics, Inc. 0.49% Equity (common) US
TECH Bio-Techne Corp. 0.46% Equity (common) US
Geographic Breakdown
Chart
Seasonality
'23'24'25'26Avg
Jan--0.91%7.45%1.04%3.13%
Feb--2.40%0.41%0.20%1.00%
Mar--1.30%-2.70%-5.49%-2.30%
Apr---2.86%-1.01%-0.88%-1.58%
May--1.30%-2.74%2.71%0.42%
Jun--1.97%1.21%7.91%3.70%
Jul--3.11%-3.46%-2.02%-0.79%
Aug--4.49%4.55%3.75%4.26%
Sep---3.51%1.59%-3.29%-1.74%
Oct---3.94%1.57%1.82%*-0.18%
Nov4.58%-1.45%8.78%--3.97%
Dec4.85%-11.96%-0.88%---2.66%
Total9.65%-9.00%14.87%5.22%5.19%
* Only 4 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $60.77
SMA 50: $61.74
SMA 200: $58.67
Current: $60.55
EMA 12: $60.37
EMA 26: $60.89
MACD: -0.5152 | Signal: -0.0408
BEARISH
ADX (14): 16.72
RANGE
+DI: 43.16
−DI: 49.99

Momentum Oscillators

RSI (14): 46.79
NEUTRAL
Stoch %K: 27.80
Stoch %D: 21.64
Williams %R: -55.24

Volume & Volatility

BB Upper: $62.23
BB Lower: $59.31
NEUTRAL
OBV: 13,994
Vol SMA 20: 217
Vol ROC: 78.95%
ATR: $0.45
True Range: $0.84
HV 20: 12.5%
HV 30: 13.3%
HV 60: 14.9%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-10T00:00:00 – 2026-10-09T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All JDOC news →

JDOC Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 0.3940
Alpha: 5.90%
Correlation: 0.3426
R-Squared: 11.7%
Stock Volatility: 15.0%
Market Volatility: 13.1%

Analysis Details

Benchmark: SPY
Data Points: 250
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time

JDOC Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

6 filers104,461 shares$6.33M value
# Filer Shares Value % of Total % of Float Period
1 JPMorgan Chase & Co Custodian 88,196 $5.35M 84.53% — 2026-06-30
2 Citadel Advisors LLC Custodian 7,460 $449.32K 7.10% — 2026-06-30
3 Krilogy Financial LLC 4,427 $266.64K 4.21% — 2026-06-30
4 Sanctuary Advisors, LLC 4,152 $250.09K 3.95% — 2026-06-30
5 Royal Bank of Canada Custodian 120 $7.00K 0.11% — 2026-06-30
6 Wells Fargo & Company Custodian 106 $6.38K 0.10% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
JDOC Constituent Performance

Click any bar to view the full quote for that stock.

JDOC Constituents (42 of 42)
Symbol Name Weight % Price 1 Day 1 Week 1 Month
JNJ Johnson & Johnson 7.43% $261.44 +1.93%+2.11%-1.56%
LLY Eli Lilly & Co. 7.20% $1179.27 +0.83%+3.19%+5.70%
ABBV AbbVie, Inc. 5.41% $276.47 +1.49%+5.19%+7.53%
MRK Merck & Co., Inc. 5.11% $145.6 +2.26%+0.90%+1.16%
UNH UnitedHealth Group, Inc. 3.49% $379.3 +2.25%+1.99%+0.06%
DHR Danaher Corp. 3.16% $219.81 +1.08%+2.69%+9.83%
BMY Bristol-Myers Squibb Co. 2.43% $59.12 -0.77%-3.32%-7.10%
BSX Boston Scientific Corp. 2.42% $42.73 +1.64%+0.31%-0.58%
CVS CVS Health Corp. 2.40% $86.16 -1.87%-0.35%-8.98%
MCK McKesson Corp. 2.09% $938.84 +0.92%+4.05%+6.50%
REGN Regeneron Pharmaceuticals, Inc. 2.09% $746.54 +0.94%+1.54%-4.47%
VRTX Vertex Pharmaceuticals, Inc. 1.84% $510.08 +1.36%+1.06%-1.04%
SYK Stryker Corp. 1.71% $277.33 +0.13%+0.69%+0.64%
TMO Thermo Fisher Scientific, Inc. 1.67% $658.02 +0.93%+0.49%+7.90%
CAH Cardinal Health, Inc. 1.66% $237.57 -0.58%+4.06%+1.28%
EW Edwards Lifesciences Corp. 1.65% $85.21 +1.15%+0.07%+1.00%
IQV IQVIA Holdings, Inc. 1.43% $259.88 +0.39%+0.65%-0.72%
ISRG Intuitive Surgical, Inc. 1.35% $423.96 +2.06%+8.17%+14.85%
BIIB Biogen, Inc. 0.94% $225.71 +3.33%+2.65%+3.94%
AXSM Axsome Therapeutics, Inc. 0.90% $168.35 -1.02%-6.08%-23.74%
IONS Ionis Pharmaceuticals, Inc. 0.89% $45.28 +4.57%+4.00%-16.47%
APGE Apogee Therapeutics, Inc. 0.83% $135.07 -0.01%+0.09%+0.63%
NBIX Neurocrine Biosciences, Inc. 0.77% $142.44 +0.84%-0.52%-8.82%
ASND Ascendis Pharma A/S 0.77% $229.23 +2.94%+0.60%-13.01%
UTHR United Therapeutics Corp. 0.73% $549.16 +3.07%+1.38%+10.47%
IMNM Immunome, Inc. 0.70% $19.55 +1.24%-6.46%-20.75%
IRON Disc Medicine, Inc. 0.67% $62.06 +2.12%-3.80%-11.42%
VRDN Viridian Therapeutics, Inc. 0.66% $18.66 +1.74%-3.81%-12.15%
DYN Dyne Therapeutics, Inc. 0.65% $16.64 +1.65%+9.47%-8.62%
CGON CG oncology, Inc. 0.62% $63.82 +0.89%-5.28%-11.79%
RVMD Revolution Medicines, Inc. 0.50% $189.76 +0.87%-8.17%-6.88%
WAT Waters Corp. 0.49% $433.77 +1.08%+2.01%+6.23%
CYTK Cytokinetics, Inc. 0.49% $62.91 +1.45%-4.10%-14.72%
TECH Bio-Techne Corp. 0.46% $72.46 +0.01%+0.08%+0.47%
CI Cigna Group (The) 0.44% $282.43 +0.50%+4.40%+0.59%
XENE Xenon Pharmaceuticals, Inc. 0.43% $36.44 +0.77%-4.16%-37.87%
ALGN Align Technology, Inc. 0.42% $142.71 +1.19%-0.72%-5.38%
TERN Terns Pharmaceuticals, Inc. 0.36% $52.95 +0.04%+0.00%+0.32%
HCA HCA Healthcare, Inc. 0.33% $451.09 +1.37%+5.72%+5.66%
ALNY Alnylam Pharmaceuticals, Inc. 0.32% $232.68 +3.63%+5.90%-6.43%
GMAB Genmab A/S 0.15% $37.07 +2.83%+6.68%+14.17%
LEGN Legend Biotech Corp. 0.03% $18.62 -0.48%+0.27%-0.11%